TY - JOUR
KW - Analgesics, Opioid/therapeutic use
KW - Drug Overdose/drug therapy/prevention & control
KW - Humans
KW - Naloxone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - Outpatients
KW - Pain Management
KW - palliative care
KW - naloxone
KW - Opioid
KW - Overdose
KW - prevention
KW - Safety
AU - L. M. Coons
AU - Gardea Hart
AU - A. White
AU - S. Summers
A1 - 
AB - Over the past two decades, opioid use and overdose have increased substantially. Naloxone, an opioid overdose reversal agent, has been one of many risk mitigation strategies for preventing mortality due to overdose. Most literature describing naloxone utilization has been about populations of illicit drug users and patients in hospitals, primary care, and pharmacies. There is limited information regarding naloxone prescribing and training for opioid users in specialty pain management clinics. Furthermore, there are no known publications concerning patients receiving palliative care services and overdose prevention. Pain and palliative care patients are commonly at risk of opioid overdose. In an interdisciplinary outpatient pain and palliative care clinic, pharmacists implemented naloxone prescribing and education. Eleven patients at increased risk for overdose were prescribed naloxone and educated on overdose risk factors, recognition, and management. Seven patients reported picking up their naloxone prescription from the pharmacy, and none reported using it within two weeks of the initial education. This intervention was deemed successful within the clinic, but small sample size and the pharmacist role may not be replicable within other pain and palliative care settings. It encourages further research of overdose risk and prevention in pain management and palliative care.
BT - Journal of pain & palliative care pharmacotherapy
C5 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
CP - 2
CY - England
DO - 10.1080/15360288.2020.1843587
IS - 2
JF - Journal of pain & palliative care pharmacotherapy
LA - eng
M1 - Journal Article
N2 - Over the past two decades, opioid use and overdose have increased substantially. Naloxone, an opioid overdose reversal agent, has been one of many risk mitigation strategies for preventing mortality due to overdose. Most literature describing naloxone utilization has been about populations of illicit drug users and patients in hospitals, primary care, and pharmacies. There is limited information regarding naloxone prescribing and training for opioid users in specialty pain management clinics. Furthermore, there are no known publications concerning patients receiving palliative care services and overdose prevention. Pain and palliative care patients are commonly at risk of opioid overdose. In an interdisciplinary outpatient pain and palliative care clinic, pharmacists implemented naloxone prescribing and education. Eleven patients at increased risk for overdose were prescribed naloxone and educated on overdose risk factors, recognition, and management. Seven patients reported picking up their naloxone prescription from the pharmacy, and none reported using it within two weeks of the initial education. This intervention was deemed successful within the clinic, but small sample size and the pharmacist role may not be replicable within other pain and palliative care settings. It encourages further research of overdose risk and prevention in pain management and palliative care.
PP - England
PY - 2021
SN - 1536-0539; 1536-0288
SP - 100
EP - 105
EP - 
T1 - Naloxone Prescribing and Education in Outpatient Pain Management and Palliative Care
T2 - Journal of pain & palliative care pharmacotherapy
TI - Naloxone Prescribing and Education in Outpatient Pain Management and Palliative Care
U1 - Education & Workforce; Healthcare Disparities; Opioids & Substance Use
U2 - 33844624
U3 - 10.1080/15360288.2020.1843587
VL - 35
VO - 1536-0539; 1536-0288
Y1 - 2021
Y2 - Jun
ER -